Kenji Kojima

Title: Kenji Kojima: Innovator in Recombinant Technology

Introduction

Kenji Kojima is a notable inventor based in Kakamigahara, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant expression systems. His work focuses on enhancing the production of valuable enzymes through innovative methods.

Latest Patents

Kojima holds a patent for a recombinant expression plasmid vector and a recombinant strain used in producing oxalate decarboxylase. The patent aims to provide a means of highly producing oxalate decarboxylase originating from microorganisms. The recombinant expression plasmid vector he developed contains an α-amylase promoter and an oxalate decarboxylase gene, which is controlled by the promoter. This vector is used to transform a host bacterium, enabling the preparation of an oxalate decarboxylase producing bacterium. The process involves culturing the producing bacterium and recovering the recombinant oxalate decarboxylase produced.

Career Highlights

Kenji Kojima is currently employed at Amano Enzyme Inc., where he continues to advance his research in enzyme production. His innovative approaches have positioned him as a key figure in the biotechnology sector.

Collaborations

Kojima has collaborated with notable colleagues, including Takahumi Koyama and Yuzo Kojima. Their combined expertise has contributed to the success of various projects within the company.

Conclusion

Kenji Kojima's work in recombinant technology exemplifies the impact of innovation in biotechnology. His contributions, particularly in enzyme production, highlight the importance of research and development in advancing scientific knowledge and applications.